Bank Pictet & Cie Europe AG Purchases 9,872 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bank Pictet & Cie Europe AG increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 263,655 shares of the healthcare conglomerate’s stock after purchasing an additional 9,872 shares during the quarter. UnitedHealth Group comprises 2.9% of Bank Pictet & Cie Europe AG’s holdings, making the stock its 6th biggest position. Bank Pictet & Cie Europe AG’s holdings in UnitedHealth Group were worth $133,373,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $37,000. Friedenthal Financial bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $51,000. Highline Wealth Partners LLC bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $55,000. Finally, Legacy Investment Solutions LLC bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $57,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $523.48 on Friday. The firm has a market cap of $481.75 billion, a PE ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a fifty day moving average price of $523.63 and a 200 day moving average price of $563.48.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the business posted $5.83 EPS. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on UNH shares. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Stephens boosted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Finally, KeyCorp restated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.